As of December 31, 2025, Lipum AB (publ) has 21.21M shares outstanding.
| Shares Outstanding | 21.21M |
These figures are as of December 31, 2025.
| PB Ratio | -1.29 |
| P/TBV Ratio | -65.31 |
| P/FCF Ratio | -8.96 |
| P/OCF Ratio | -8.87 |
As of December 31, 2025, Lipum AB (publ) maintains a current ratio of 0.58, meaning it holds 0.6x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 0.58 |
| Quick Ratio | 0.13 |
| Interest Coverage | -23.22 |
These figures cover the twelve months ended December 31, 2025. Return on assets (ROA) is negative at -273.04, reflecting losses generated across the asset base.
| Return on Assets (ROA) | -273.04 |
These figures cover the twelve months ended December 31, 2025. Free cash flow yield is negative at -11.16: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield is negative at -9.64, meaning Lipum AB (publ) raised more capital through share issuance and new debt than it returned via dividends and buybacks.
| Shareholder Yield | -9.64 |
| FCF Yield | -11.16 |
Lipum AB (publ)'s most recent stock split took place on April 4, 2024 with a 500:519 split ratio.
| Last Split Date | 4/4/2024 |
| Split Ratio | 500:519 |
As of December 31, 2025, Lipum AB (publ) has an Altman Z-Score of -76.72, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -76.72 |
Already premium?